Sacubitril/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation.

Qiqi WangChengui ZhuoQi XiaJiajia JiangBifeng WuDongchen ZhouZheyue ShuJianqiang ZhaoMiao ChenHeng ChenZewei SunBiqi ZhangJie HanLiang-Rong Zheng

Published in: Cardiovascular drugs and therapy (2022)

SV can decrease AF recurrence after catheter ablation in patients with persistent AF at the 1-year follow-up. The mechanism for this process may be related to the reduction in the H2FPEF score in patients with preserved ejection fraction heart failure.

Keyphrases

atrial fibrillation
catheter ablation
ejection fraction
heart failure
left atrial
aortic stenosis
left atrial appendage
oral anticoagulants
direct oral anticoagulants
percutaneous coronary intervention
left ventricular
cardiac resynchronization therapy
venous thromboembolism